Table 1 Cohort characteristics
MMNP | MPC | PMMST | ENID (2 years) | ENID (6 years) | ALSPAC | |
---|---|---|---|---|---|---|
Child parameters | ||||||
Sample size (post QC) | 698 (685) | 557 (553) | 289 (284) | 239 (238) | 144 (142) | 925 (863) |
Male (%) | 377 (55.0%) | 271 (49.0%) | 129 (44.6%) | 122 (51.2%) | 81 (57.0%) | 424 (49.2%) |
Median age in years (IQR) | 5.80 (5.63–6.00) | 5.00 (4.98–5.01) | 9.00 (8.61–9.21) | 2.00 (2.00–2.01) | 6.20 (5.71–6.61) | 7.40 (7.23–7.57) |
Mean height in cm (SD) | 109.60 (4.93) | 105.60 (4.31) | 130.00 (5.65) | 82.70 (3.03) | 113.00 (4.79) | 126.10 (5.20) |
Mean height for age, HAZ (SD) | −1.01 (0.96) | −0.86 (0.91) | −0.33 (0.89) | −1.33 (0.96) | −0.66 (0.77) | 0.37 (0.93) |
Stunted (%)a | 105 (15.3%) | 55 (9.9%) | 22 (7.7%) | 56 (23.5%) | 7 (4.9%) | 5 (0.6%) |
Country (ethnicity) | India (SAS) | India (SAS) | Gambia (AFR) | Gambia (AFR) | Gambia (AFR) | United Kingdom (EUR) |
Maternal parameters | ||||||
Sample size (max N) | 683 | 553 | 276 | 238 | 142 | 863 |
Mean BMI kg/m2 (SD)b | 20.30 (3.73) | 23.60 (3.58) | 21.60 (3.62) | 21.16 (3.56) | 21.05 (3.05) | 22.90 (3.81) |
Mean gestational age in weeks (SD) | 38.70 (2.18) | 39.10 (1.69) | 39.70 (2.88) | 39.70 (0.96) | 39.80 (0.91) | 39.60 (1.50) |
Nutritional intervention (vs control) | Maternal MMN (Food-based) | None | Maternal MMN (Tablet-based) | Maternal /infant MMN/lipid/Fe-Fol supplementation | None | |
DNA methylation platformc | EPIC | EPIC | EPIC | 450 K | EPIC | 450 K |
Main cohort reference (PMID) | Potdar et al.59 (25332324) | Krishnaveni et al.20 (24609067) | Owens et al.64 (26561613) | Moore et al.21 (23057665) | Moore et al.21 (23057665) |